Clinical Trial Update: The Effects of Erythropoietin on Clinical Disability and Brain Pathology in Patients With Progressive Multiple Sclerosis [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update investigates the effects of erythropoietin on clinical disability and brain pathology in patients with progressive multiple s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Multiple Sclerosis (Primary or Secondary Progressive Phase). | Phase 2 | Status: UNKNOWN